NBRV logo

Nabriva Therapeutics (NBRV) Current Assets

Annual Current Assets

$31.10 M
-$49.16 M-61.25%

December 31, 2022


Summary


Performance

NBRV Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Quarterly Current Assets

$23.69 M
-$7.41 M-23.82%

March 31, 2023


Summary


Performance

NBRV Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

NBRV Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-61.3%-63.7%
3 y3 years-65.9%-37.9%
5 y5 years-66.8%-76.0%

NBRV Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-61.2%at low-70.5%at low
5 y5-year-65.9%at low-75.0%at low
alltimeall time-73.2%-87.0%-81.8%-83.0%

Nabriva Therapeutics Current Assets History

DateAnnualQuarterly
Mar 2023
-
$23.69 M(-23.8%)
Dec 2022
$661.00 K(+2.6%)
$31.10 M(-34.6%)
Sep 2022
-
$47.56 M(-12.4%)
Jun 2022
-
$54.30 M(-16.7%)
Mar 2022
-
$65.20 M(-18.8%)
Dec 2021
$644.00 K(-47.1%)
$80.27 M(-9.2%)
Sep 2021
-
$88.41 M(-6.6%)
Jun 2021
-
$94.62 M(+20.6%)
Mar 2021
-
$78.44 M(+37.1%)
Dec 2020
$1.22 M(-58.6%)
$57.22 M(+5.4%)
Sep 2020
-
$54.31 M(-13.0%)
Jun 2020
-
$62.41 M(+63.5%)
Mar 2020
-
$38.17 M(-58.1%)
Dec 2019
$2.94 M(+76.8%)
$91.17 M(+5.5%)
Sep 2019
-
$86.41 M(+7.9%)
Jun 2019
-
$80.09 M(-20.3%)
Mar 2019
-
$100.48 M(-7.6%)
DateAnnualQuarterly
Dec 2018
$1.67 M(-13.5%)
$108.75 M(-1.7%)
Sep 2018
-
$110.68 M(+30.3%)
Jun 2018
-
$84.95 M(-13.8%)
Mar 2018
-
$98.50 M(+5.0%)
Dec 2017
$1.92 M(-26.5%)
$93.84 M(-20.4%)
Sep 2017
-
$117.87 M(+86.4%)
Jun 2017
-
$63.23 M(-17.4%)
Mar 2017
-
$76.58 M(-15.5%)
Dec 2016
$2.62 M(+78.6%)
$90.62 M(+9.0%)
Sep 2016
-
$83.15 M(-12.0%)
Jun 2016
-
$94.44 M(-12.5%)
Mar 2016
-
$107.98 M(-7.1%)
Dec 2015
$1.47 M(+85.5%)
$116.25 M(-10.7%)
Sep 2015
-
$130.12 M(+209.9%)
Jun 2015
-
$41.99 M(+690.3%)
Mar 2015
-
$5.31 M(+31.9%)
Dec 2014
$790.40 K(-15.2%)
$4.03 M
Dec 2013
$932.10 K
-

FAQ

  • What is Nabriva Therapeutics annual total current assets?
  • What is the all time high annual current assets for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual current assets year-on-year change?
  • What is Nabriva Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly current assets year-on-year change?

What is Nabriva Therapeutics annual total current assets?

The current annual current assets of NBRV is $31.10 M

What is the all time high annual current assets for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual total current assets is $116.25 M

What is Nabriva Therapeutics annual current assets year-on-year change?

Over the past year, NBRV annual total current assets has changed by -$49.16 M (-61.25%)

What is Nabriva Therapeutics quarterly total current assets?

The current quarterly current assets of NBRV is $23.69 M

What is the all time high quarterly current assets for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly total current assets is $130.12 M

What is Nabriva Therapeutics quarterly current assets year-on-year change?

Over the past year, NBRV quarterly total current assets has changed by -$41.51 M (-63.66%)